Although the quarterly wasn't great (not bad either), it's encouraging to see an increase in volume these last few weeks (we previously saw weeks going past without a trade)
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025